Abstract

The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act

Author(s): Pore R David

Issue: Nov/Dec 2012 - Volume 16, Number 6

Page(s): 446-450

Download in electronic PDF format for $75

Abstract

This article provides a summary of the Drug Enforcement Agency’s current interpretation of the Controlled Substances Act as it relates to the “constructive transfer” of certain controlled substances from pharmacist to physician for office administration. The article discusses compliance with the Controlled Substances Act in this context and related legislative and legal activities of individual pharmacists and of the International Academy of Compounding Pharmacists and other groups.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2012 Pg. 446-450	The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Author(s): Pore R David
Mar/Apr 2012 Pg. 94-96 View Sample	The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Author(s): Miller David G
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Sep/Oct 2020 Pg. 371-379	Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Mar/Apr 2015 Pg. 104-106	Standing Together Fixing the Drug Quality and Security Act Author(s): Miller David G
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 92	PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 400-403	Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Author(s): Gilbert John A
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 431-433	Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Jan/Feb 2002 Pg. 8-10	Compounding with Controlled Substances Author(s): Whalen Mary Kate
Jan/Feb 2014 Pg. 35-36	U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Author(s): Miller David G
Sep/Oct 2012 Pg. 382-384	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Mar/Apr 2014 Pg. 94-99	A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Author(s): Marks Zach
Mar/Apr 2016 Pg. 148-154	Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) Author(s): Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Sep/Oct 2018 Pg. 401-404	Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Author(s): Martin Matt